These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 38551748)

  • 1. Community pharmacists' views and experiences of delivering in-pharmacy medication reviews for people living with severe and persistent mental illness: a qualitative study.
    Ng R; El-Den S; Collins JC; McMillan SS; Hu J; Wheeler AJ; O'Reilly CL
    Int J Clin Pharm; 2024 Aug; 46(4):862-871. PubMed ID: 38551748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploring the implementation of a novel community pharmacist-led support service for people living with severe and persistent mental illness.
    Ng R; El-Den S; Collins JC; Stewart V; McMillan SS; Hu J; Wheeler AJ; O'Reilly CL
    Res Social Adm Pharm; 2024 Jun; 20(6):113-122. PubMed ID: 38467520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bridging the gap between physical and mental illness in community pharmacy (
    Wheeler AJ; O'Reilly CL; El-Den S; Byrnes J; Ware RS; McMillan SS
    BMJ Open; 2020 Jul; 10(7):e039983. PubMed ID: 32709657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of a training program to support the implementation of a community pharmacist-led support service for people living with severe and persistent mental illness.
    Ng R; El-Den S; Collins JC; Hu J; McMillan SS; Wheeler AJ; O'Reilly CL
    J Am Pharm Assoc (2003); 2023; 63(3):807-816.e2. PubMed ID: 36788042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medication-related problems identified by community pharmacists: a descriptive case study of two Australian populations.
    Collins JC; Hu J; McMillan SS; O'Reilly CL; El-Den S; Kelly F; Spinks J; Riley T; Wheeler AJ
    J Pharm Policy Pract; 2023 Nov; 16(1):133. PubMed ID: 37919809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Community pharmacists' attitudes toward providing care and services to patients with severe and persistent mental illness.
    Watkins A; McKee J; Hughes C; Pfeiffenberger T
    J Am Pharm Assoc (2003); 2017; 57(3S):S217-S224.e2. PubMed ID: 28408170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploring pharmacists' views on an in-pharmacy medication review program in Australia using a mixed-methods design.
    Buss VH; Shield A; Kosari S; Peterson GM; Naunton M
    Int J Clin Pharm; 2020 Dec; 42(6):1385-1395. PubMed ID: 32803556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Qualitative exploration of the experiences of community pharmacists delivering the Diabetes MedsCheck service.
    Gargya D; Mirkazemi C; Curtain C
    J Clin Pharm Ther; 2022 Aug; 47(8):1194-1200. PubMed ID: 35322454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experiences of goal planning in Australian community pharmacy settings for people experiencing mental illness: A qualitative study.
    Stewart V; McMillan SS; Hu J; Collins JC; El-Den S; O'Reilly C; Wheeler AJ
    Health Expect; 2023 Dec; 26(6):2205-2215. PubMed ID: 37424358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. From personal crisis care to convenience shopping: an interpretive description of the experiences of people with mental illness and addictions in community pharmacies.
    Murphy AL; Martin-Misener R; Kutcher SP; O'Reilly CL; Chen TF; Gardner DM
    BMC Health Serv Res; 2016 Oct; 16(1):569. PubMed ID: 27729051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacists' roles in supporting people living with severe and persistent mental illness: a systematic review protocol.
    El-Den S; McMillan SS; Wheeler AJ; Ng R; Roennfeldt H; O'Reilly CL
    BMJ Open; 2020 Jul; 10(7):e038270. PubMed ID: 32665350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploring current and potential roles of Australian community pharmacists in gout management: a qualitative study.
    Counsell AB; Nguyen AD; Baysari MT; Kannangara DRW; McLachlan AJ; Day RO
    BMC Fam Pract; 2018 May; 19(1):54. PubMed ID: 29743018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perinatal depression screening in community pharmacy: Exploring pharmacists' roles, training and resource needs using content analysis.
    Strowel C; Raynes-Greenow C; Pham L; Carter S; Birkness K; Moles RJ; O'Reilly CL; Chen TF; Raduescu C; Murphy A; Gardner D; El-Den S
    Int J Clin Pharm; 2023 Oct; 45(5):1212-1222. PubMed ID: 37792255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacists' views on Indigenous health: is there more that can be done?
    Stoneman J; Taylor SJ
    Rural Remote Health; 2007; 7(3):743. PubMed ID: 17688377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular disease risk screening by pharmacists: a behavior change wheel guided qualitative analysis.
    Almansour HA; Mekonnen AB; Aloudah NM; Alhawassi TM; Mc Namara K; Chaar B; Krass I; Saini B
    Res Social Adm Pharm; 2020 Feb; 16(2):149-159. PubMed ID: 31027964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A qualitative study of community pharmacists' opinions on the provision of osteoporosis disease state management services in Malaysia.
    Nik J; Lai PS; Ng CJ; Emmerton L
    BMC Health Serv Res; 2016 Aug; 16(1):448. PubMed ID: 27577560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structured medication reviews in Parkinson's disease: pharmacists' views, experiences and needs - a qualitative study.
    Oonk NGM; Dorresteijn LDA; Te Braake E; Movig KLL; van der Palen J; Nijmeijer HW; van Kesteren ME; Bode C
    Ther Adv Drug Saf; 2024; 15():20420986241237071. PubMed ID: 38694547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implementation of a mental health medication management intervention in Australian community pharmacies: Facilitators and challenges.
    Hattingh HL; Kelly F; Fowler J; Wheeler AJ
    Res Social Adm Pharm; 2017; 13(5):969-979. PubMed ID: 28583302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Community pharmacy integration within the primary care pathway for people with long-term conditions: a focus group study of patients', pharmacists' and GPs' experiences and expectations.
    Hindi AMK; Schafheutle EI; Jacobs S
    BMC Fam Pract; 2019 Feb; 20(1):26. PubMed ID: 30736732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Community pharmacists' experiences in mental illness and addictions care: a qualitative study.
    Murphy AL; Phelan H; Haslam S; Martin-Misener R; Kutcher SP; Gardner DM
    Subst Abuse Treat Prev Policy; 2016 Jan; 11():6. PubMed ID: 26821700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.